Mesoblast awarded FDA approval for Ryoncil
Mesoblast (ASX:MSB) has received approval from the US Food and Drug Administration (FDA) for Ryoncil (remestemcel-L), making ...
ABx Group and ALCORE Secure Tasmanian Government Support for World-First Pilot Plant
ABx Group Limited (ASX:ABX) and its 83%-owned subsidiary, ALCORE Limited, are making significant strides in advancing their ...
Wesfarmers to sell Coregas for $770m to Nippon Sanso Holdings
Wesfarmers (ASX:WES) has announced an agreement to sell its Coregas business to a subsidiary of Nippon Sanso Holdings ...
Peninsula restarts uranium production after five-year pause
Peninsula Energy (ASX:PEN) has restarted uranium production at its Lance Projects in Wyoming, USA, following a five-year ...
North American Graphite Producers Seek 920% Tariff on Chinese Imports to Counter Unfair Practices
North American graphite producers have formally requested the U.S. government to impose a tariff as high as 920% on Chinese ...
Dow’s losing streak snapped, but ASX set for stumble
The Dow Jones Industrial Average has narrowly ended its longest losing streak since 1974. Investor sentiment remains cautious ...
Radiopharm gets green light for Phase 1 cancer trial
Radiopharm Theranostics (ASX:RAD) has received approval from the Belberry Human Research Ethics Committee to commence the ...
AGL hit with $25m penalty over Centrepay breach
AGL Energy (ASX:AGL) has been ordered by the Federal Court to pay $25m in penalties after it was found that four AGL ...
Heartbeats, no strings attached: EBR’s big step toward FDA approval
EBR Systems (ASX:EBR) has announced that the FDA will conduct a Pre-Approval Inspection of its manufacturing facility during ...
Woodside swaps assets with Chevron
Woodside Energy (ASX:WDS) has announced an asset swap with Chevron. The deal will see Woodside strengthen its position in ...
Driving on a foggy night: Fed cuts by 0.25%, but signals fewer cuts ahead
The Federal Reserve cut its target interest rate by 25 basis points, bringing the federal funds rate to a range of 4.25% to 4 ...
Hawkish Fed tilt, More spending in MYEFO, PMIs point to lower inflation ahead, Wealth boost to slow
Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and ...